Alzheimer's drugs linked to lower death, heart attack risk

06/5/2013 | MedPage Today (free registration)

Alzheimer's disease patients who took cholinesterase inhibitors to improve cognitive function were 34% less likely to die and experience myocardial infarction than non-users, researchers found. The risk of myocardial infarction was lowest among those who took the highest doses. The study, based on data from more than 7,000 patients in Sweden, was published in the European Heart Journal.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL